Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Neogen (NEOG) Shares Outstanding (Diluted Average) (2018 - 2022)

Historic Shares Outstanding (Diluted Average) for Neogen (NEOG) over the last 5 years, with Q4 2022 value amounting to $216.1 million.

  • Neogen's Shares Outstanding (Diluted Average) rose 9989.83% to $216.1 million in Q4 2022 from the same period last year, while for Nov 2022 it was $216.1 million, marking a year-over-year increase of 9989.83%. This contributed to the annual value of $108.0 million for FY2022, which is 84.02% up from last year.
  • As of Q4 2022, Neogen's Shares Outstanding (Diluted Average) stood at $216.1 million, which was up 9989.83% from $107.9 million recorded in Q3 2022.
  • Neogen's Shares Outstanding (Diluted Average)'s 5-year high stood at $216.1 million during Q4 2022, with a 5-year trough of $52.1 million in Q2 2018.
  • Over the past 5 years, Neogen's median Shares Outstanding (Diluted Average) value was $107.0 million (recorded in 2020), while the average stood at $100.3 million.
  • As far as peak fluctuations go, Neogen's Shares Outstanding (Diluted Average) soared by 10243.93% in 2021, and later dropped by 23.31% in 2022.
  • Neogen's Shares Outstanding (Diluted Average) (Quarter) stood at $52.1 million in 2018, then increased by 1.39% to $52.9 million in 2019, then skyrocketed by 102.0% to $106.8 million in 2020, then grew by 1.23% to $108.1 million in 2021, then soared by 99.9% to $216.1 million in 2022.
  • Its Shares Outstanding (Diluted Average) stands at $216.1 million for Q4 2022, versus $107.9 million for Q3 2022 and $108.0 million for Q2 2022.